phenylalanyl-leucyl-arginyl phenylalaninamide has been researched along with guanosine triphosphate in 1 studies
| Studies (phenylalanyl-leucyl-arginyl phenylalaninamide) | Trials (phenylalanyl-leucyl-arginyl phenylalaninamide) | Recent Studies (post-2010) (phenylalanyl-leucyl-arginyl phenylalaninamide) | Studies (guanosine triphosphate) | Trials (guanosine triphosphate) | Recent Studies (post-2010) (guanosine triphosphate) |
|---|---|---|---|---|---|
| 40 | 0 | 0 | 14,728 | 25 | 2,115 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ellis, AM; Huddart, H | 1 |
1 other study(ies) available for phenylalanyl-leucyl-arginyl phenylalaninamide and guanosine triphosphate
| Article | Year |
|---|---|
Excitation evoked by FMRFamide and FLRFamide in the heart of Buccinum undatum and evidence for inositol 1,4,5-trisphosphate as an RF-tetrapeptide second messenger.
Topics: Animals; Anticoagulants; Antimanic Agents; Bivalvia; Dose-Response Relationship, Drug; FMRFamide; Guanosine Triphosphate; Heparin; Inositol 1,4,5-Trisphosphate; Lithium Chloride; Membrane Potentials; Myocardial Contraction; Myocardium; Neomycin; Oligopeptides; Protein Synthesis Inhibitors; Second Messenger Systems; Serotonin; Type C Phospholipases | 2000 |